approved EB-1A
Senior Biostatistician
Epidemiology · India · 2025-02-26
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
3 of 3 criteria metScholarly Articles (Met)
The petitioner authored 11 peer-reviewed journal articles and 6 conference abstracts in high-impact journals.
Judging (Met)
The petitioner completed at least 75 reviews for journals in her field of expertise.
Original Contributions (Met)
Her research in biostatistics and pharmacoepidemiology has been cited 394 times and implemented by others in the field.
Why This Petition Was Approved
The petition was approved based on a strong record of 11 peer-reviewed journal articles, 1 accepted article, and 6 conference abstracts published in high-impact journals. The petitioner demonstrated her influence through 394 citations from scholars in at least 42 countries. Additionally, her participation in the field was evidenced by conducting at least 75 peer reviews for professional journals.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Conference Presentations
Judging Experience
Original Contributions
Evidence Submitted
- 11 peer-reviewed journal articles (1 first-authored)
- 1 accepted journal article
- 6 conference abstracts (1 first-authored)
- 394 citations according to Google Scholar
- Citations originating from at least 42 countries
- 75 peer reviews conducted for journals
- M.B.B.S. degree and specialized expertise in pharmacoepidemiology
Similar Cases
Others
Research and Development · China
WeGreened EB-1A approved
New York 438 days 2025-04-03
The petition was approved based on meeting at least three EB-1A criteria: authorship of 15 peer-reviewed journal articles, a significant citation record of 771 citations, and the completion of 27 peer reviews for professional journals. Additionally, the work was supported by prestigious funding from the NIH, NSF, and Pfizer.
Postdoctoral Researcher
Healthcare · Sweden
WeGreened EB-1A approved
California 20 days 2025-02-13
The petition was approved based on meeting at least three EB-1A criteria: authorship of scholarly articles, participation as a judge of others' work, and original contributions of major significance. Specific metrics included 21 peer-reviewed journal articles, 877 citations, and the completion of at least 10 peer reviews.
Postdoctoral Researcher
Healthcare · Ethiopia
WeGreened EB-1A approved
Ohio 227 days 2025-06-03
The petition was approved based on 41 peer-reviewed journal articles, 10 abstracts, and 2307 citations with an h-index of 24. The petitioner satisfied EB-1A criteria through original contributions of major significance, scholarly articles, and a leading role in the field as a guest and handling editor. His work was recognized as being in the top 1% of medical research publications over the last eight years.
Lecturer
Research and Development · Ethiopia
WeGreened EB-1A approved
65 days 2025-10-24
The petition was approved based on the petitioner's authorship of 36 peer-reviewed journal articles and 1,517 citations, placing him in the top 1% of his field. Additionally, he performed 26 peer reviews and served as a Ph.D. dissertation committee member, satisfying the criteria for judging, original contributions, and scholarly articles.
Frequently Asked Questions
A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-26.
Browse all casesAt a Glance
Outcome approved
Processing 400 days
Criteria Met 3 / 3
Evidence Types 6
EB-1A Case Data
Scraped Case Data
Total Cases 919
Success Rate 53.0%
Sustained 487
Dismissed 315
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist